The attorneys general of New York, California, Massachusetts and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, the so-called “abortion pill.” The four states have requested that the FDA remove mifepristone from the Risk Evaluation and Mitigation Strategies (REMS) program, “including [...]